RSS

acquired thrombotic thrombocytopenia purpura (aTTP)

Biopharmaceutical company, Ablynx, has announced the completion of patient recruitment for its Phase III HERCULES study of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP). more

3 May 2017 11:46 News